acifran has been researched along with 3-hydroxybutyric acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, TQ; Chen, R; Cheng, K; Connolly, D; Gan, X; Ippolito, M; Jin, L; Kaplan, R; Kero, J; Liaw, C; Offermanns, S; Ren, N; Richman, J; Taggart, AK; Waters, MG; Wright, SD; Wu, K; Wu, TJ | 1 |
1 other study(ies) available for acifran and 3-hydroxybutyric acid
Article | Year |
---|---|
(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.
Topics: 3-Hydroxybutyric Acid; Adipocytes; Animals; Cell Line; Feedback, Physiological; Humans; Hyperlipidemias; Hypolipidemic Agents; Ligands; Lipolysis; Mice; Nicotinic Agonists; Receptors, G-Protein-Coupled; Receptors, Nicotinic | 2005 |